↓ Skip to main content

Neurofeedback to improve neurocognitive functioning of children treated for a brain tumor: design of a randomized controlled double-blind trial

Overview of attention for article published in BMC Cancer, December 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter
6 tweeters
facebook
3 Facebook pages

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
140 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neurofeedback to improve neurocognitive functioning of children treated for a brain tumor: design of a randomized controlled double-blind trial
Published in
BMC Cancer, December 2012
DOI 10.1186/1471-2407-12-581
Pubmed ID
Authors

Marieke A de Ruiter, Antoinette YN Schouten-Van Meeteren, Rosa van Mourik, Tieme WP Janssen, Juliette EM Greidanus, Jaap Oosterlaan, Martha A Grootenhuis

Abstract

Neurotoxicity caused by treatment for a brain tumor is a major cause of neurocognitive decline in survivors. Studies have shown that neurofeedback may enhance neurocognitive functioning. This paper describes the protocol of the PRISMA study, a randomized controlled trial to investigate the efficacy of neurofeedback to improve neurocognitive functioning in children treated for a brain tumor.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 1%
Germany 1 <1%
United Kingdom 1 <1%
Unknown 136 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 24 17%
Student > Ph. D. Student 20 14%
Researcher 18 13%
Student > Bachelor 15 11%
Student > Doctoral Student 10 7%
Other 26 19%
Unknown 27 19%
Readers by discipline Count As %
Psychology 52 37%
Medicine and Dentistry 24 17%
Neuroscience 9 6%
Nursing and Health Professions 7 5%
Agricultural and Biological Sciences 4 3%
Other 14 10%
Unknown 30 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2015.
All research outputs
#3,270,465
of 16,578,610 outputs
Outputs from BMC Cancer
#812
of 6,056 outputs
Outputs of similar age
#48,286
of 260,744 outputs
Outputs of similar age from BMC Cancer
#39
of 327 outputs
Altmetric has tracked 16,578,610 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,056 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 260,744 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 327 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.